Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferences

View all Images (53)

Incontinentia pigmenti in Child
Other Resources UpToDate PubMed

Incontinentia pigmenti in Child

Contributors: Mehdi Rashighi MD, Belinda Tan MD, PhD, Susan Burgin MD
Other Resources UpToDate PubMed

Synopsis

Incontinentia pigmenti (IP), or Bloch-Sulzberger syndrome, is an X-linked dominant disease mainly of females that is lethal in males, caused by a mutation in the IKBKG gene. The disease is noticed at birth or within the first few weeks of life. The disease typically progresses through 4 stages: vesicular, verrucous, hyperpigmentation, and hypopigmentation / atrophy. Most cases are associated with developmental abnormalities of the skin, hair, nails, teeth, eyes, and central nervous system. Intellectual disability and epilepsy can be associated. Ocular findings, if present, include both retinal and nonretinal abnormalities, usually related to vascular occlusion.

Codes

ICD10CM:
Q82.3 – Incontinentia pigmenti

SNOMEDCT:
367520004 – Incontinentia pigmenti syndrome

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

To perform a comparison, select diagnoses from the classic differential

Subscription Required

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed:01/15/2018
Last Updated:01/17/2022
Copyright © 2024 VisualDx®. All rights reserved.
Incontinentia pigmenti in Child
A medical illustration showing key findings of Incontinentia pigmenti (Stage 1) : Linear configuration, Vesicles, Erythematous plaques
Clinical image of Incontinentia pigmenti - imageId=119964. Click to open in gallery.  caption: 'The vesicular stage, showing patterned erythematous plaques and fine vesiculation on the arm.'
The vesicular stage, showing patterned erythematous plaques and fine vesiculation on the arm.
Copyright © 2024 VisualDx®. All rights reserved.